Cytomegalovirus Prophylaxis With Intravenous Polyvalent Immunoglobulin in High-Risk Renal Transplant Recipients
Fanny Leroy(Centre Hospitalier Universitaire de Poitiers), Guy Touchard(Centre Hospitalier Universitaire de Poitiers), A. Séchet(Centre National de la Recherche Scientifique), Éstelle Desport(Centre Hospitalier Universitaire de Poitiers), Frank Bridoux(Université de Poitiers), Antoine Thierry(Université de Poitiers), R. Abou Ayache(Centre Hospitalier Universitaire de Poitiers), Marc Bauwens(Centre Hospitalier Universitaire de Poitiers), S. Belmouaz(Université de Poitiers)
Cited by 16
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group
|Nature Reviews Nephrology|2018|544
Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant
|Blood|2012|543
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis
|New England Journal of Medicine|2007|520